Amrocip-500 Tablet
Ciprofloxacin 500 mg Tablets — Standard Adult Fluoroquinolone Antibiotic
| Composition | Ciprofloxacin Hydrochloride 500 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Blister |
| Pack Size | 10 x 10 Tablets |
| MRP | ₹ 476 |
| Therapy | Antibiotic + G.P. + Orthopaedics + Gynaecology — Fluoroquinolone Antibiotic |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Amrocip-500 Tablet
Amrocip-500 Tablet is the standard adult-strength Ciprofloxacin 500 mg tablet for the treatment of bacterial infections that require higher tissue concentrations than the 250 mg strength provides. The 500 mg twice-daily regimen is used for complicated urinary tract infections, lower respiratory infections, bone and joint infections, and bacterial prostatitis.
Ciprofloxacin’s broad coverage of gram-negative organisms (Enterobacteriaceae, Pseudomonas), atypical pathogens, and selected gram-positive bacteria makes it one of the most versatile oral antibiotics in primary care. Its excellent bioavailability and tissue penetration — particularly into urine, prostate and respiratory secretions — support its position in multiple specialty treatment guidelines.
Amrocip-500 is manufactured by Trumac Healthcare under WHO-GMP conditions and is one of the company’s flagship antibiotic SKUs. Available for monopoly-based PCD pharma franchise, government tenders and third-party manufacturing.
Indications
- Complicated urinary tract infections (including pyelonephritis)
- Bacterial prostatitis (acute and chronic)
- Community-acquired pneumonia (with macrolide)
- Acute exacerbations of COPD
- Bone and joint infections
- Severe traveller's diarrhoea and shigellosis
- Anthrax post-exposure prophylaxis
Mechanism of Action
Ciprofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV — enzymes essential for DNA replication, transcription, and repair. By preventing supercoiling and chromosome decatenation, ciprofloxacin produces rapid concentration-dependent bactericidal activity with a sustained post-antibiotic effect.
Dosage & Administration
Adults: 500 mg twice daily for 7–14 days; complicated infections may require longer. Adjust dose in renal impairment. Take with water; avoid antacids/iron/calcium/dairy within 2 hours.
Side Effects
Nausea, diarrhoea, headache, dizziness, taste disturbance. Class effects: tendinopathy and tendon rupture (Achilles), QT prolongation, peripheral neuropathy, CNS effects, photosensitivity, dysglycaemia. Risk of C. difficile colitis. Rare: aortic aneurysm/dissection risk in susceptible elderly patients.
Contraindications & Precautions
Hypersensitivity to quinolones. Children/adolescents except specific indications. Pregnancy and lactation. Concomitant tizanidine. Tendon disorder history with quinolones. Caution: QT-prolonging drugs, epilepsy, myasthenia gravis, antidiabetics, aortic disease.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
Amrocip-500 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Amrocip-500 Tablet used for?
Amrocip-500 contains Ciprofloxacin 500 mg, used for complicated urinary tract infections, bacterial prostatitis, lower respiratory infections, bone and joint infections, and severe gastroenteritis.
What is the difference between Amrocip-250 and Amrocip-500?
Same molecule, different strengths. Amrocip-250 is for uncomplicated, lower-severity infections; Amrocip-500 is the standard adult strength for moderate-to-severe and complicated infections.
Is Amrocip-500 available for PCD pharma franchise?
Yes, Trumac Healthcare offers Amrocip-500 Tablet on monopoly-based PCD pharma franchise, government tenders and third-party manufacturing.
How should Amrocip-500 Tablet be stored?
Store below 30 °C in a dry place, away from direct sunlight and moisture.
Is Amrocip-500 WHO-GMP certified?
Yes, Amrocip-500 Tablet is manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Amrocip-250 Tablet — Ciprofloxacin 250 mg
- Amrocip-TZ Tablet — Ciprofloxacin HCl 500 mg + Tinidazole 600 mg
- Amiza-500 Injection — Amikacin 500 mg / 2 ml